≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Malignant immunoproliferative diseases

Endpoint Browser PheWeb

CD2_IMMUNOPROLIFERATIVE_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C88
  • Cause of death: ICD-10 — C88

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Morbi immunoproliferativi maligni

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 319 124 195
Unadjusted period prevalence (%) 0.07 0.04 0.09
Median age at first event (years) 67.83 65.99 69.00

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
293
Matched controls
2928
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
256.4
207
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
181.3
166.6
163
20
XW000
NOMESCO Finland
Bone marrow biopsy
79.6
128.8
142
34
9761/3-C42.0
ICD-O-3
Waldenstrom macroglobulinemia of blood
+∞
86.8
79
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
109.1
69.8
74
9
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
63.9
59
*
L03AA02
ATC
filgrastim; parenteral
344.2
57.4
56
*
A04AA01
ATC
ondansetron; systemic, rectal
33.7
50.4
66
25
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
93.7
49.9
54
7
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
49.4
46
*
JN4BD
NOMESCO Finland
Extensive body CT
18.5
49.0
78
56
H02AB02
ATC
dexamethasone; systemic
149.8
48.4
50
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
46.0
43
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
43.8
41
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
42.7
40
*
L03AA13
ATC
pegfilgrastim; parenteral
417.0
37.9
37
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
36.2
34
*
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
17.8
35.9
57
39
WW500
NOMESCO Finland
Blood transfusion
25.8
34.4
48
22
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
12.5
34.3
64
64
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.5
32.3
96
205
JN4AD
NOMESCO Finland
Body CT examination
15.5
31.7
53
41
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
28.6
27
*
A03FA01
ATC
metoclopramide; systemic, rectal
6.3
27.9
82
169
A04AA02
ATC
granisetron; systemic, transdermal
+∞
27.5
26
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
296.4
27.2
27
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
26.4
25
*
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
26.4
25
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
26.4
25
*
M04AA01
ATC
allopurinol; systemic
4.8
26.2
104
302
ZX120
NOMESCO Finland
Intravenous
8.0
25.9
62
95
C88.7
ICD-10 Finland
Other malignant immunoproliferative diseases
+∞
23.2
22
*
390
Kela drug reimbursment
Ibrutinib
+∞
23.2
22
*
1512
Kela drug reimbursment
Ibrutinib
+∞
23.2
22
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
12.1
22.7
42
40
R50.9
ICD-10 Finland
Fever, unspecified
5.0
22.2
80
205
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
22.1
21
*
L01AA02
ATC
chlorambucil; oral
236.6
21.9
22
*
1XC02
NOMESCO Finland
NA
112.6
19.8
21
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
18.9
18
*
D64.9
ICD-10 Finland
Anaemia, unspecified
5.1
18.9
64
151
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
18.8
170
907
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
17.9
17
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
17.9
17
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
17.9
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
16.9
93
341
H02AB06
ATC
prednisolone; systemic
2.9
16.8
173
976
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
16.8
16
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
16.8
16
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.5
16.5
63
168
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.2
16.2
104
427
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
63.6
15.9
18
*
L01EL01
ATC
ibrutinib; oral
+∞
15.8
15
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
15.8
15
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
89.9
15.7
17
*
J05AB11
ATC
valaciclovir; oral
4.1
15.3
64
185
J05AB01
ATC
aciclovir; systemic
3.4
15.2
87
326
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
14.7
14
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
157.3
14.6
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.3
14.0
20
10
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
13.6
13
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
13.6
13
*
N08.1*C88.0
ICD-10 Finland
Glomerular disorders in Waldenström's macroglobulinaemia
+∞
13.6
13
*
130
Kela drug reimbursment
Malignant tumour
+∞
13.6
13
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
146.3
13.6
14
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
12.8
38
76
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
12.6
12
*
116
Kela drug reimbursment
Prostate cancer
+∞
12.6
12
*
J01MA12
ATC
levofloxacin; systemic
3.2
12.5
76
292
ZX112
NOMESCO Finland
Subcutaneous
39.3
12.3
15
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
39.3
12.3
15
*
JN6AD
NOMESCO Finland
CT of torso and neck
39.3
12.3
15
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
13.2
12.3
21
17
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
48.7
12.0
14
*
JN4CD
NOMESCO Finland
Very extensive body CT
13.3
11.8
20
16
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
67.6
11.7
13
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
45.1
11.0
13
*
B03XA01
ATC
erythropoietin; parenteral
22.4
10.8
15
7
N02AA05
ATC
oxycodone; systemic
3.3
10.5
55
189
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
113.8
10.5
11
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
+∞
10.5
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
10.5
10
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
10.5
10
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
10.5
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
10.4
85
390
D70.89
ICD-10 Finland
Neutropenic splenomegaly
33.8
10.4
13
*
B03XA02
ATC
darbepoetin alfa; parenteral
11.9
10.2
18
16
J01MA14
ATC
moxifloxacin; systemic
4.0
10.0
41
115
L01AA01
ATC
cyclophosphamide; systemic
27.0
9.9
13
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
9.8
108
578
127
Kela drug reimbursment
Transplant complication
18.3
9.5
14
8
WZC30
NOMESCO Finland
Teaching
3.8
9.5
41
121
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
10.5
9.1
17
17
WW200
NOMESCO Finland
Immunization
7.9
9.1
20
27
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
37.9
9.1
11
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.7
9.0
22
35
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
8.8
36
101
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.0
8.7
35
97
A02BC02
ATC
pantoprazole; systemic
2.1
8.7
196
1422
UJF32
NOMESCO Finland
Coloscopy
2.3
8.5
90
468
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
8.4
97
526
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
8.4
8
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
8.4
8
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
8.4
8
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
15.0
8.3
13
9
ZXE00
NOMESCO Finland
One hour or less
2.1
8.2
118
704
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.2
8.2
14
12
TAB00
NOMESCO Finland
Lumbar puncture
6.2
8.1
21
36
PJA10
NOMESCO Finland
Exploration of lymph nodes
34.3
8.1
10
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.5
8.1
15
15
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.2
8.1
24
49
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
8.0
115
683
A41.9
ICD-10 Finland
Sepsis, unspecified
5.1
8.0
24
50
B01AB10
ATC
tinzaparin; parenteral
5.2
7.8
23
47
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.3
7.7
38
125
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
82.0
7.4
8
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
7.4
63
292
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
7.3
7
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
7.3
38
131
XX3DW
NOMESCO Finland
Time consuming IT work
4.6
7.2
24
56
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.2
7.2
15
19
WF002
NOMESCO Finland
Radical radiotherapy
30.8
7.2
9
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
4.3
6.9
24
59
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
17.2
6.8
10
6
HAB40
NOMESCO Finland
Wedge excision of mammary gland
41.0
6.8
8
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.5
6.7
30
92
C03CA01
ATC
furosemide; systemic
2.0
6.7
115
723
Z51.5
ICD-10 Finland
Palliative care
5.0
6.7
20
42
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
6.5
115
729
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
6.5
38
142
L02AE02
ATC
leuprorelin; implant, parenteral
71.2
6.4
7
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
14.7
6.4
10
7
L04AA06
ATC
mycophenolic acid; systemic
9.6
6.3
12
13
C88.3
ICD-10 Finland
Immunoproliferative small intestinal disease
+∞
6.3
6
*
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
6.3
6
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
6.3
6
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
6.3
6
*
L02BG04
ATC
letrozole; oral
+∞
6.3
6
*
L01BB05
ATC
fludarabine; systemic
+∞
6.3
6
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
6.3
6
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
6.3
6
*
1AA09
NOMESCO Finland
NA
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
6.3
6
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
6.3
6
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
6.2
30
98
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
6.2
100
612
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
10.3
6.1
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037756) Immunofixation for Serum or Plasma
154
40
73.50
266.27
2.1
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
208
136
42.08
264.63
12.5
1.3
g/l
13.7
1.1
28.55
199
127
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
160
69
45.52
237.69
7.4
1.4
ratio
8.2
0.9
—
7
9
(3034860) Kappa light chains.free [Mass/volume] in Serum
161
72
44.13
236.06
7.4
1.3
mg/l
110.8
44.6
3.08
135
58
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
161
73
43.51
234.82
7.4
1.3
mg/l
29.7
33.1
0.31
136
59
(40760888) Immunoglobulin light chains.free panel - Serum
140
49
50.14
221.44
7.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
203
177
29.79
220.33
11.1
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
231
259
29.71
217.11
10.1
2.8
u/l
226.5
241.3
0.98
224
245
(3045142) Bone marrow Pathology biopsy report
105
21
74.04
188.82
1.5
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
178
167
22.85
181.94
6.1
1.9
g/l
7.8
10.9
7.54
173
151
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
132
83
26.42
164.71
10.5
1.2
g/l
8.0
0.3
11.20
111
74
(3042111) Morphology [Interpretation] in Bone marrow Narrative
107
43
36.94
159.33
1.6
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
101
21.04
144.85
10.1
1.2
g/l
7.0
7.7
2.35
95
79
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
101
21.04
144.85
10.1
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
101
21.04
144.85
10.0
1.2
g/l
3.9
3.9
0.05
84
75
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
96
19.70
132.55
10.5
1.3
g/l
3.0
3.1
0.39
86
76
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
118
93
19.55
129.56
10.2
1.2
g/l
15.2
10.6
3.78
95
80
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
100
67
21.28
118.91
2.5
1.5
—
—
—
0
0
(4035726)
101
74
19.51
114.53
2.0
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
70
24
37.09
108.16
1.9
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
67
28
30.02
96.60
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
170
338
9.63
93.38
5.9
2.2
%
1.7
1.7
0.21
160
305
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
92
82
15.36
92.41
10.7
1.2
g/l
37.5
38.0
0.29
80
69
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
105
117
12.89
91.24
2.9
1.7
g/l
1.5
1.5
0.01
92
102
(46235355) HIV 1 and 2 tests - Meaningful Use set
139
226
10.13
90.52
1.9
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
126
184
10.67
89.45
2.0
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
99
109
12.72
86.46
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
121
177
10.40
85.46
2.0
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
142
261
9.00
82.38
5.4
2.2
e9/l
65.3
66.2
0.09
118
201
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
62
37
20.56
76.64
7.6
7.1
iu/ml
928.9
136.0
—
8
6
(3007164) IgA [Mass/volume] in Serum or Plasma
163
417
6.95
66.74
4.0
1.2
g/l
1.3
2.8
15.25
144
238
(3011412) CD3 cells [#/volume] in Blood
44
19
26.70
61.92
3.0
1.8
e9/l
1.3
1.4
0.12
27
11
(42870588) Differential panel, method unspecified - Blood
218
779
6.68
60.57
15.8
5.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
98
167
8.03
59.11
7.5
3.9
%
0.8
0.8
0.00
62
41
(3026493) Urate [Moles/volume] in Serum or Plasma
198
698
5.84
54.32
7.3
2.6
umol/l
1564.9
9400.5
2.34
189
601
(3003458) Phosphate [Moles/volume] in Serum or Plasma
128
314
6.14
53.14
12.3
5.3
mmol/l
1.1
1.0
0.40
122
283
(3018010) Neutrophils/100 leukocytes in Blood
251
1104
6.97
52.49
14.5
5.2
%
54.8
57.8
3.08
244
1023
(3001604) Monocytes [#/volume] in Blood
260
1180
7.51
52.46
14.8
5.0
e9/l
0.6
0.6
0.86
241
1010
(3019198) Lymphocytes [#/volume] in Blood
262
1201
7.61
52.15
14.9
5.1
e9/l
1.9
1.8
0.29
247
1046
(3006315) Basophils [#/volume] in Blood
260
1186
7.45
51.96
14.8
5.0
e9/l
0.0
0.0
0.85
241
1022
(40768795) Lymph node Pathology biopsy report
33
10
36.69
51.85
1.7
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
264
1226
7.69
51.53
16.2
5.1
e9/l
0.2
0.2
2.25
249
1064
(3017817) Protein [Mass] in Urine collected for unspecified duration
42
26
18.45
50.43
2.1
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
269
1302
7.80
49.11
28.3
6.0
e9/l
3.4
4.3
14.14
250
1135
(3002179) Metamyelocytes/100 leukocytes in Blood
84
149
7.30
48.18
8.1
4.0
%
0.5
0.3
0.37
40
32
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
35
16
24.45
47.89
1.7
1.9
%
13.0
10.0
—
7
10
(3021440) Promyelocytes/100 leukocytes in Blood
86
159
7.04
47.35
8.0
3.9
%
0.0
0.1
0.56
55
36
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
50
51
11.44
44.79
2.9
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
256
1250
6.31
44.23
19.5
5.9
mmol/l
1.2
1.2
0.25
219
1073
(3024561) Albumin [Mass/volume] in Serum or Plasma
235
1075
5.50
43.88
10.3
3.6
g/l
33.2
35.2
4.89
230
988
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
43
38
12.92
42.23
2.5
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
48
11.31
41.99
3.5
1.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
123
366
4.84
39.25
8.8
3.3
mmol/l
0.8
0.8
1.47
118
339
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
31
17
20.09
39.13
2.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
31
17
20.09
39.13
2.0
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
14
22.69
38.63
1.8
2.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
43
7
70.64
38.20
1.4
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
182
750
4.32
37.16
13.8
3.2
ph
7.4
7.4
0.43
44
124
(3025159) Blasts/100 leukocytes in Blood
73
152
5.93
35.00
7.9
4.0
%
0.0
0.0
0.07
43
33
(3017704) Immunofixation for Urine
28
16
19.09
34.59
1.3
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
38
10.88
32.72
2.3
1.3
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
36
8
50.50
30.34
3.0
1.4
e9/l
0.1
0.2
—
36
8
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
15
18.00
30.09
4.2
1.9
e6/l
328.8
1257.6
—
16
5
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
33
11.04
29.65
2.1
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
154
5.34
29.45
2.8
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
31
11.36
29.37
2.1
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
32
11.00
28.73
1.8
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
353
4.06
28.66
4.1
2.4
%
24.2
22.9
0.36
97
308
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
29
25
12.66
28.66
2.3
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
160
695
3.61
28.32
11.1
3.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
28
11.72
28.19
2.4
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
119
431
3.81
27.73
4.7
2.0
s
31.4
30.0
1.15
113
412
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
155
671
3.55
27.38
2.8
2.1
mg/l
3.2
3.1
0.29
137
562
(3022948) Iron [Moles/volume] in Serum or Plasma
117
423
3.79
27.27
3.7
2.3
umol/l
11.6
13.0
1.32
112
385
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
27
11.71
27.27
2.4
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
30
30
10.93
26.90
2.4
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
19
14.19
26.55
2.5
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
19
14.19
26.55
2.5
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
19
14.19
26.55
2.5
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
28
26
11.71
26.35
2.0
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
26
22
12.78
25.92
9.3
4.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
22
14
16.80
25.63
2.7
2.6
%
35.3
55.0
—
7
5
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
31
35
9.70
25.48
2.2
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
51
7.83
24.70
1.3
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
167
797
3.30
24.49
6.5
2.2
mmol/l
2.3
2.4
0.32
150
654
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
32
9.87
24.21
1.8
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
114
434
3.53
24.16
3.1
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
188
979
3.24
23.47
4.9
2.7
ug/l
222.0
135.7
2.48
180
886
(21494814) CD8 cells/100 lymphocytes in Specimen
27
5
58.71
23.44
1.5
1.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
27
5
58.71
23.44
1.6
1.6
%
3.4
3.2
—
27
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
45
8.06
23.35
1.8
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
119
475
3.40
23.26
12.3
3.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
45
88
5.79
22.67
3.2
3.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
48
100
5.47
22.58
1.6
2.6
u/l
39.9
40.1
0.02
42
88
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
29
36
8.76
22.11
2.4
1.9
pg
33.4
33.2
0.10
29
36
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
19
12.36
21.57
1.2
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
22
19
12.36
21.57
2.6
2.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
145
684
3.05
20.92
6.3
2.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
33
52
6.96
20.52
1.8
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
55
141
4.51
20.18
2.8
1.4
ug/l
9.3
5.0
0.27
39
109
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
11
16.27
19.49
4.7
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
24
7
36.90
19.18
1.3
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
18
0
+∞
18.94
5.3
0.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
183
1027
2.83
18.48
7.9
3.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
27
9.10
18.24
2.4
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
120
543
2.94
18.19
21.2
4.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
30
8.57
18.13
1.9
1.1
u/ml
262.3
259.6
0.01
15
16
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
11
15.26
17.74
2.1
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
16
11.86
17.24
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
185
1076
2.71
16.91
25.6
8.3
e9/l
0.0
0.0
0.52
163
886
(40768804) Tissue Pathology biopsy report
139
702
2.74
16.85
2.4
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
166
921
2.67
16.60
4.7
3.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
526
2.82
16.39
6.0
2.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
41
6.82
16.09
5.7
2.1
%
53.5
60.2
1.11
26
41
(44790049)
21
26
8.58
15.94
2.6
1.5
—
—
—
0
0
(44806118)
21
26
8.58
15.94
2.6
1.5
—
—
—
0
0
(44790048)
21
26
8.58
15.94
2.6
1.5
—
—
—
0
0
(44790047)
21
26
8.58
15.94
2.6
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
120
578
2.73
15.78
9.2
3.9
%
84.1
85.1
0.16
114
567
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
80
312
3.09
15.53
2.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
80
313
3.08
15.44
2.8
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
40
6.70
15.25
4.6
1.5
e9/l
2.8
5.1
4.12
25
40
(3037121) Protein [Mass/volume] in Urine
37
86
4.74
15.20
2.1
2.1
g/l
1.4
0.2
0.54
21
28
(3019832) Treponema pallidum Ab [Presence] in Serum
35
79
4.85
14.89
1.4
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
76
296
3.06
14.73
1.4
1.3
titre
220.0
556.6
—
8
71
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
36
6.81
14.30
1.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
88
379
2.83
14.17
2.5
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
115
570
2.59
13.99
1.9
1.8
nmol/l
1161.6
1185.2
0.09
90
433
(3013707) Erythrocyte sedimentation rate by Westergren method
258
1874
2.97
13.73
8.1
4.2
mm/h
45.8
12.4
28.58
245
1700
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
17
5
35.77
13.64
1.0
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
26
49
5.69
13.48
1.4
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
28
59
5.11
12.86
1.5
1.2
e6/l
8.3
58.1
0.45
20
45
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
28
59
5.11
12.86
1.6
1.3
e6/l
146.2
2038.9
0.50
20
47
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
5
33.55
12.69
4.9
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
138
779
2.36
12.33
4.8
3.0
e6/l
30.8
150.2
0.76
118
590
(36304419) Bacteria [Presence] in Urine
126
686
2.38
12.21
4.7
2.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
28
62
4.85
12.14
1.4
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
152
904
2.30
11.92
5.4
3.5
e6/l
76.8
115.1
0.45
121
639
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
9
19.86
11.71
2.9
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
9
19.86
11.71
2.9
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
9
19.86
11.71
2.9
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
9
19.86
11.71
2.9
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
29
69
4.52
11.54
2.3
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
17
24
7.43
11.53
1.8
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
20
34
6.21
11.47
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
34
92
4.02
11.46
1.5
1.7
—
124.0
—
0
5
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
100
503
2.44
11.45
4.9
2.2
mmol/l
2.5
2.4
4.23
90
427
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
24
50
5.11
11.15
1.6
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
11
11.30
11.12
2.4
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
172
1103
2.21
10.94
11.2
10.8
inr
1.2
1.4
1.29
51
308
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
7
22.39
10.78
3.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
7
22.39
10.78
3.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
7
22.39
10.78
3.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
17
8.57
10.69
2.9
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
53
201
2.96
10.58
4.8
3.8
ng/l
98.0
87.5
0.29
47
176
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
88
3.93
10.54
6.8
4.1
u/ml
0.3
0.4
1.05
15
45
(3030467) Casts [#/volume] in Urine by Automated count
125
716
2.23
10.41
4.8
2.9
e6/l
0.7
0.4
0.38
106
526
(3037467) Urinalysis macro (dipstick) panel - Urine
233
1710
2.34
10.38
5.8
4.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
27
6.59
10.38
1.1
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
96
493
2.36
10.36
4.1
2.6
mosm/kgh2o
512.1
556.9
1.58
82
399
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
8
19.59
10.36
3.7
3.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
15
8.99
10.30
1.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
15
21
7.45
10.22
1.1
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
10
11.36
10.21
1.3
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
102
541
2.30
10.19
3.7
2.3
e6/l
3.2
4.1
0.93
91
465
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
151
946
2.13
9.90
3.8
3.4
ng/l
1811.3
1554.3
0.28
133
804
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
11
10.32
9.59
2.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
14
8
18.23
9.48
2.3
1.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
8
18.23
9.48
2.3
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
6
22.50
9.42
1.1
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
21
6.93
8.97
2.4
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
50
202
2.75
8.83
3.0
1.9
g/l
0.2
0.2
2.93
42
176
(3042631) Mycobacterium sp identified in Specimen
17
32
5.56
8.78
2.7
2.8
—
—
—
0
0
(3002256) Pathology report gross observation
47
185
2.81
8.72
1.4
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
96
526
2.18
8.68
3.2
1.8
mg/l
2.4
1.1
0.72
83
414
(3021960) Folate [Moles/volume] in Serum or Plasma
120
723
2.06
8.42
2.0
1.5
nmol/l
22.3
20.4
0.47
109
603
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
26
6.00
8.40
3.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
126
774
2.04
8.37
3.4
3.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
0
+∞
8.37
1.5
0.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
150
982
2.00
8.32
3.0
2.2
nmol/l
83.2
78.9
0.78
137
840
(3024471) HLA-A [Type]
13
9
14.99
8.27
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
23
6.32
8.25
1.9
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
52
222
2.60
8.23
15.2
9.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
27
5.78
8.10
3.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
27
5.78
8.10
3.3
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
27
5.78
8.10
3.3
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
15
27
5.78
8.10
1.9
1.2
e6/l
739.9
2949.6
—
10
19
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
27
5.78
8.10
3.3
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
27
5.78
8.10
3.2
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
304
2.38
8.07
2.3
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
31
5.38
8.01
1.7
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
44
4.53
7.79
1.1
1.8
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
32
5.21
7.74
1.5
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
48
204
2.59
7.65
14.0
2.7
mmol/l
1.2
1.2
0.29
48
169
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
12
9
13.79
7.44
5.4
2.8
%
96.9
77.9
—
12
9
(3024932) HLA-DR beta [Type]
12
9
13.79
7.44
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
9
13.79
7.44
1.5
1.0
—
—
—
0
0
(4062490)
14
26
5.59
7.31
1.3
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
19
6.52
7.29
2.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
11
16
7.08
7.19
1.3
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
10
5
20.57
7.17
2.9
4.2
%
153.4
91.8
—
10
5
(3035880) pH of Pleural fluid
10
13
7.91
7.16
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
23
5.85
7.12
5.2
2.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
82
455
2.08
7.01
4.0
2.7
e6/l
1.6
1.1
0.35
58
262
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
20
6.20
6.95
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
76
412
2.11
6.90
4.3
3.0
e6/l
1.8
2.3
0.35
52
221
(3007853) Bacteria identified in Skin by Aerobe culture
59
289
2.28
6.88
2.0
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
94
552
2.00
6.86
1.5
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
165
1169
1.85
6.77
2.6
2.0
pmol/l
93.7
93.0
0.05
106
602
(40768797) Stomach Pathology biopsy report
65
340
2.15
6.44
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
104
2.97
6.35
3.6
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
22
5.63
6.33
1.2
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
22
5.63
6.33
1.8
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
52
3.82
6.30
1.9
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
52
3.82
6.30
1.9
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
19
52
3.82
6.30
5.0
3.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
30
4.83
6.27
5.4
3.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
93
565
1.91
6.06
3.9
4.2
ng/l
1110.8
346.7
0.44
79
481
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
45
209
2.34
5.91
3.8
2.1
u/l
26.6
34.1
1.35
37
174
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
39
170
2.47
5.88
2.2
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
36
152
2.54
5.80
2.5
2.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
119
797
1.79
5.61
3.9
2.2
u/l
57.8
57.8
0.00
112
727
(3009343) pH of Capillary blood
42
194
2.34
5.58
8.5
5.3
ph
7.4
7.4
—
9
20
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
53
272
2.14
5.48
5.5
3.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
43
3.86
5.44
5.6
2.9
—
—
—
0
0
(3019225) pH of Specimen
50
252
2.17
5.41
10.6
3.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
30
4.47
5.34
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
54
282
2.10
5.33
11.7
3.7
mmol/l
2.6
2.0
0.50
44
234
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
8
11.53
5.32
2.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
8
11.53
5.32
2.4
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
46
226
2.21
5.29
14.2
8.6
mmol/l
1.5
1.4
0.14
46
216
(3015736) pH of Urine
136
961
1.72
5.23
3.9
3.5
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
5
0
+∞
5.22
5.4
0.0
umol/l
0.3
—
—
5
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.22
1.2
0.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
76
3.04
5.14
1.5
2.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
34
150
2.42
5.00
3.7
2.7
e9/l
3.2
3.9
0.86
21
103
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
20
67
3.12
4.92
2.1
1.4
iu/ml
8.4
0.3
—
6
13
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
7
11.68
4.81
1.3
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
167
2.30
4.74
1.9
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
29
4.26
4.67
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
160
1208
1.65
4.63
4.7
3.6
estimate
0.0
0.0
0.00
34
207
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
25
4.52
4.60
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
5
14.27
4.59
1.4
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
5
14.27
4.59
1.3
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
8
10.22
4.54
6.3
5.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
26
4.35
4.39
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
159
1210
1.63
4.38
6.3
4.9
estimate
0.0
0.0
0.00
33
203
(3023419) Bacteria identified in Sputum by Culture
15
45
3.45
4.38
2.9
3.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
161
1230
1.62
4.36
4.7
3.7
estimate
0.0
0.0
0.00
33
200
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
9
9.08
4.30
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
6
11.89
4.29
1.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
36
3.72
4.25
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
32
3.86
4.12
1.1
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
278
2469
1.98
4.12
47.3
13.6
mg/l
23.7
24.4
0.15
262
1919
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
10
8.17
4.08
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
10
8.17
4.08
1.3
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
53
3.13
4.02
3.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
53
3.13
4.02
3.9
2.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
17
60
2.94
3.85
4.1
1.5
u/ml
33.4
33.5
0.00
17
60
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
64
396
1.77
3.79
1.4
1.3
iu/ml
56.6
34.0
0.27
16
118
(3003396) Base excess in Arterial blood by calculation
54
319
1.83
3.72
10.8
8.0
mmol/l
1.1
1.5
0.35
43
246
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
146
1120
1.56
3.70
5.6
4.0
ng/l
49.8
71.3
0.31
118
856
(3028626) Oxygen [Partial pressure] in Capillary blood
19
74
2.67
3.62
10.4
5.9
kpa
8.7
8.2
0.52
19
69
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
59
362
1.77
3.59
1.3
1.3
u/ml
0.9
11.4
2.60
17
125
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
9
7.92
3.57
2.6
1.3
nmol/l
2.8
4.5
—
7
9
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
26
3.94
3.55
1.2
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
17
5.41
3.53
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
13
6.28
3.52
2.9
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
40
219
1.94
3.47
2.6
1.6
nmol/l
329.1
363.6
0.55
40
200
(4027681)
9
18
5.11
3.39
1.6
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
17
65
2.71
3.36
3.7
1.9
g/l
118.6
129.8
0.66
12
46
(3052851) Hemolysis interference index of Serum or Plasma
18
71
2.63
3.36
3.5
3.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
24
110
2.28
3.28
1.7
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
7
8.71
3.27
1.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
9
19
4.84
3.26
2.4
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
19
4.84
3.26
1.6
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
15
5.44
3.21
1.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
11
6.48
3.20
1.3
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
20
4.60
3.13
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
87
2.39
3.07
1.8
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
8
7.62
3.06
1.2
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
12
5.94
3.03
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
36
200
1.90
3.00
1.5
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
5
10.13
2.99
4.0
8.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
5
10.13
2.99
1.2
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
35
3.22
2.96
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
35
196
1.88
2.86
2.5
2.0
ml/min/173m2
44.6
59.1
1.57
16
83
(3022313) Gas panel - Capillary blood
28
145
2.02
2.85
10.0
5.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
26
132
2.06
2.79
15.3
12.3
mmol/l
24.3
24.8
0.33
26
117
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
6
8.44
2.76
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
19
4.29
2.69
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
93
2.23
2.67
2.8
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
15
4.75
2.61
1.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
15
4.75
2.61
1.7
2.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
15
4.75
2.61
1.0
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
242
2151
1.52
2.60
44.1
15.2
%
34.9
39.4
7.17
156
1371
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
7
7.23
2.56
4.0
2.1
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
11
5.53
2.55
11.2
1.4
u/l
177.2
206.6
—
6
11
(3019060) Gas panel - Arterial blood
34
196
1.82
2.55
6.0
4.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
179
1511
1.42
2.46
6.0
3.1
u/l
59.8
51.3
0.63
164
1380
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
125
1.99
2.43
14.8
13.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
36
215
1.76
2.41
1.6
1.8
%
1.7
1.7
0.04
29
178
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
12
5.07
2.41
1.7
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
12
5.07
2.41
2.3
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
231
1.73
2.40
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
22
3.70
2.38
2.3
2.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
9
28
3.28
2.32
1.6
1.3
pmol/l
86.3
79.6
—
9
28
(40768441) Liver Pathology biopsy report
6
13
4.68
2.28
2.0
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
109
853
1.42
2.25
2.1
2.2
u/l
97.2
322.6
1.83
102
792
(40761536) Microorganisms panel - Urine sediment
34
205
1.74
2.22
6.0
3.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
61
2.35
2.18
1.7
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
61
2.35
2.18
1.7
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
14
4.35
2.16
1.7
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
14
4.35
2.16
1.7
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
62
2.32
2.11
1.7
1.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
5
10
5.06
2.08
3.2
1.3
umol/l
2.5
1.4
—
5
10
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
10
5.06
2.08
17.8
7.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
10
5.06
2.08
18.2
7.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
35
218
1.68
2.04
1.7
1.9
ug/g
189.2
125.7
0.47
25
170
(3003327) Ova and parasites identified in Stool by Light microscopy
13
57
2.34
2.00
1.9
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
147
1231
1.36
1.97
3.2
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
80
605
1.43
1.97
4.8
3.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
11
4.60
1.95
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
116
941
1.37
1.89
5.1
3.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
82
628
1.41
1.88
4.1
3.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
28
2.90
1.87
1.4
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
18
94
1.97
1.84
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
54
2.27
1.76
1.3
1.2
—
—
—
0
0
(3013512) EKG study
102
819
1.36
1.75
5.1
4.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
89
1.96
1.73
1.7
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
75
2.05
1.72
1.7
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
36
238
1.58
1.69
4.7
3.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
7
25
2.84
1.66
1.7
1.7
u/ml
139.6
165.2
—
7
25
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
205
1842
1.32
1.55
3.9
3.6
pmol/l
14.7
15.1
1.46
180
1636
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
16
3.16
1.44
1.8
1.3
ug/l
34.0
16.9
—
5
16
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
22
2.76
1.44
1.7
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
6
23
2.64
1.37
1.2
1.0
ng/l
34.7
38.1
—
6
14
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
6
23
2.64
1.37
1.2
1.0
ng/l
854.3
582.6
—
6
16
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
6
23
2.64
1.37
1.2
1.0
ng/l
272.8
247.1
—
6
16
(4268621)
6
25
2.43
1.25
1.8
2.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
40
291
1.43
1.23
2.4
2.7
ug/l
15.9
7.7
0.36
34
255
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
145
0.47
1.23
2.0
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
79
1.81
1.19
3.2
4.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
52
402
1.35
1.13
30.3
25.9
inr
1.1
1.3
—
8
54
(3020564) Creatinine [Moles/volume] in Serum or Plasma
278
2650
1.38
1.13
47.5
16.3
umol/l
92.6
82.7
1.56
278
2650
(3022621) pH of Urine by Test strip
27
185
1.50
1.13
3.3
2.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
31
2.29
1.11
1.1
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
31
2.29
1.11
2.4
1.5
%
90.2
90.3
—
7
31
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
138
1215
1.24
1.10
4.5
4.1
ug/l
1.7
2.1
1.28
119
1072
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
228
2426
0.79
1.09
5.9
6.6
mmol/mol
39.5
40.9
1.70
207
2222
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
21
2.40
1.09
1.0
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
33
2.15
1.06
1.1
1.4
nmol/l
0.6
0.5
—
7
28
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
33
2.15
1.06
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
33
2.15
1.06
1.9
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
62
1.80
0.95
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
57
462
1.28
0.91
1.4
1.2
u/ml
0.6
1.3
—
8
127
(1761868) Lipid panel - Serum or Plasma
67
799
0.80
0.90
3.0
3.4
—
—
—
0
0
(4306422)
6
30
2.02
0.87
1.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
31
1.95
0.85
1.0
1.4
nmol/l
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
56
676
0.79
0.83
1.9
1.7
mmol/l
1.3
1.3
0.00
50
543
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
73
618
1.24
0.82
1.6
1.8
pmol/l
464.8
437.2
0.36
58
502
(3021788) Differential panel - Synovial fluid
8
47
1.72
0.81
1.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
124
0.55
0.79
1.4
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
79
678
1.22
0.78
5.9
3.9
estimate
0.0
0.0
0.50
29
197
(3017446) Testosterone [Moles/volume] in Serum or Plasma
24
175
1.40
0.77
1.9
2.4
nmol/l
11.9
14.8
1.21
24
151
(3044889) 12 lead EKG panel
198
1848
1.19
0.77
5.7
4.2
—
—
—
0
0
(3020891) Body temperature
18
124
1.48
0.77
5.1
4.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
39
1.81
0.73
3.1
5.3
mmol/l
6.3
7.0
—
7
31
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
238
2488
0.83
0.72
4.3
4.9
mmol/l
4.1
4.5
4.49
216
2265
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
26
195
1.36
0.72
1.1
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
26
1.94
0.71
31.4
3.7
%
7.7
11.1
—
5
26
(3000330) Specific gravity of Urine by Test strip
20
144
1.41
0.70
3.3
3.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
93
0.53
0.68
1.0
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
268
2583
1.23
0.68
35.2
13.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
28
1.80
0.66
1.2
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
70
1.59
0.66
23.9
3.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
49
1.65
0.62
1.0
1.2
—
20.7
—
0
5
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
237
2465
0.85
0.59
4.3
4.9
mmol/l
1.4
1.4
1.32
213
2227
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
252
0.74
0.59
1.6
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
36
1.68
0.57
2.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
55
1.47
0.56
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
55
1.47
0.56
2.6
2.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
90
1.46
0.56
2.3
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
37
1.63
0.56
1.0
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
246
2547
0.85
0.55
4.7
5.6
mmol/l
2.3
2.6
6.52
223
2304
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
243
2339
1.16
0.52
36.9
12.5
ml/min/173m2
74.1
74.3
0.05
219
1884
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
238
2288
1.16
0.52
4.6
4.5
mu/l
2.0
2.0
0.14
217
2038
(36660697) Celiac disease serology panel - Serum
21
163
1.31
0.49
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
49
1.44
0.46
1.1
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
232
2394
0.89
0.40
4.1
4.4
mmol/l
1.2
1.3
1.29
206
2144
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
105
972
1.12
0.40
3.9
3.9
%
21.1
24.3
1.19
51
470
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
42
1.44
0.35
4.3
2.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
43
1.40
0.35
4.3
2.5
mmol/l
107.2
105.8
—
6
43
(3041354) Potassium [Moles/volume] in Venous blood
6
43
1.40
0.35
4.3
2.5
mmol/l
4.5
4.1
—
6
43
(3012516) Albumin [Mass/volume] in Urine
97
904
1.10
0.32
5.7
3.3
mg/l
9903.6
120.8
5.26
79
584
(3007461) Platelets [#/volume] in Blood
279
2738
1.15
0.32
64.5
19.9
e9/l
233.5
240.4
0.70
274
2649
(3010813) Leukocytes [#/volume] in Blood
279
2739
1.15
0.32
64.6
20.0
e9/l
6.7
6.8
0.13
272
2638
(3026361) Erythrocytes [#/volume] in Blood
279
2739
1.15
0.32
64.5
19.9
e12/l
4.0
4.5
34.22
272
2634
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
73
674
1.11
0.29
2.9
2.8
ug/l
0.7
0.8
0.58
50
466
(3019150) Specific gravity of Urine by Refractometry
62
571
1.11
0.26
5.3
4.0
kg/l
1.0
1.0
—
10
88
(4094501)
5
71
0.70
0.26
1.0
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
18
151
1.20
0.25
12.7
2.9
%
1.1
1.1
0.02
18
151
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
75
1.21
0.25
1.3
1.3
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
11
0.00
0.21
0.0
1.0
—
21.3
—
0
11
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
150.9
—
0
11
(3006598) pH of Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
5.8
—
0
10
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
4.0
—
0
10
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
102
0.78
0.21
1.6
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.1
—
36.6
—
0
7
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.2
—
323.4
—
0
7
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
159
0.88
0.13
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
89
922
0.95
0.12
3.4
3.2
mmol/l
6.7
7.6
1.10
77
748
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
358
1.07
0.11
17.0
7.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
270
1.08
0.11
1.3
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
56
1.07
0.08
32.8
3.2
%
56.4
65.6
—
6
56
(3039443) Prostate specific Ag panel - Serum or Plasma
5
62
0.80
0.08
1.6
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
248
2502
0.96
0.08
5.0
5.0
mmol/l
6.0
6.1
0.84
218
2241
(3003338) MCHC [Mass/volume]
205
2031
1.03
0.06
57.0
18.2
g/l
329.1
332.5
5.06
205
2017
(4010399)
22
208
1.06
0.05
1.4
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
94
957
0.97
0.05
4.0
4.0
mg/mmol
17.3
7.6
0.80
63
609
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
357
0.98
0.01
4.4
4.9
%
31.6
31.6
0.01
25
229
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
115
1.05
0.00
1.0
1.2
iu/ml
26.0
88.5
—
5
42
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
52
0.96
0.00
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.9
—
1442.6
—
0
7
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
74
0.94
0.00
2.0
2.0
nmol/l
35.3
45.1
—
7
69
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
0.5
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
98
0.92
0.00
1.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
8
87
0.92
0.00
1.3
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
57.3
—
0
9
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.7
—
993.3
—
0
7
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
150.5
—
0
8
(3036071) Salmonella sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
7.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_IMMUNOPROLIFERATIVE_EXALLC – Malignant immunoproliferative diseases

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).